1. Home
  2. SLS vs PLCE Comparison

SLS vs PLCE Comparison

Compare SLS & PLCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLS
  • PLCE
  • Stock Information
  • Founded
  • SLS 2012
  • PLCE 1969
  • Country
  • SLS United States
  • PLCE United States
  • Employees
  • SLS N/A
  • PLCE N/A
  • Industry
  • SLS Biotechnology: Pharmaceutical Preparations
  • PLCE Clothing/Shoe/Accessory Stores
  • Sector
  • SLS Health Care
  • PLCE Consumer Discretionary
  • Exchange
  • SLS Nasdaq
  • PLCE Nasdaq
  • Market Cap
  • SLS 89.6M
  • PLCE 76.8M
  • IPO Year
  • SLS N/A
  • PLCE 1997
  • Fundamental
  • Price
  • SLS $1.40
  • PLCE $5.37
  • Analyst Decision
  • SLS
  • PLCE Hold
  • Analyst Count
  • SLS 0
  • PLCE 3
  • Target Price
  • SLS N/A
  • PLCE $8.33
  • AVG Volume (30 Days)
  • SLS 1.3M
  • PLCE 559.1K
  • Earning Date
  • SLS 05-13-2025
  • PLCE 04-11-2025
  • Dividend Yield
  • SLS N/A
  • PLCE N/A
  • EPS Growth
  • SLS N/A
  • PLCE N/A
  • EPS
  • SLS N/A
  • PLCE N/A
  • Revenue
  • SLS N/A
  • PLCE $1,386,269,000.00
  • Revenue This Year
  • SLS N/A
  • PLCE N/A
  • Revenue Next Year
  • SLS N/A
  • PLCE N/A
  • P/E Ratio
  • SLS N/A
  • PLCE N/A
  • Revenue Growth
  • SLS N/A
  • PLCE N/A
  • 52 Week Low
  • SLS $0.77
  • PLCE $4.77
  • 52 Week High
  • SLS $1.84
  • PLCE $19.74
  • Technical
  • Relative Strength Index (RSI)
  • SLS 72.02
  • PLCE 34.29
  • Support Level
  • SLS $1.29
  • PLCE $5.17
  • Resistance Level
  • SLS $1.38
  • PLCE $6.38
  • Average True Range (ATR)
  • SLS 0.09
  • PLCE 0.75
  • MACD
  • SLS 0.03
  • PLCE -0.07
  • Stochastic Oscillator
  • SLS 86.54
  • PLCE 9.26

About SLS SELLAS Life Sciences Group Inc.

SELLAS Life Sciences Group Inc is a late-stage clinical biopharmaceutical company focused on the development of novel therapeutics for a broad range of cancer indications. The company's product candidates currently include galinpepimut-S, or GPS, a peptide immunotherapy directed against the Wilms tumor 1, or WT1, antigen, and GFH009, a selective small molecule cyclin-dependent kinase 9, or CDK9, inhibitor.

About PLCE Children's Place Inc. (The)

Children's Place Inc operate an omni-channel children's specialty portfolio of brands in North America. It design, contract to manufacture, and sell fashionable, high-quality apparel, accessories and footwear predominantly at value prices under proprietary The Children's Place, Place, Baby Place, Gymboree, Sugar & Jade, and PJ Place brand names.

Share on Social Networks: